Latest news
Loading news…
Barinthus Biotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Harwell, Oxfordshire, United Kingdom Founded 2016 101-250 employees For Profit
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for infectious diseases and cancer.
Barinthus Biotherapeutics was acquired by Clywedog Therapeutics in 2025.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
68
Ticker
BRNS
NASDAQ
Patents
1
3 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- BRNS
- Exchange
- NASDAQ
- IPO date
- Apr 29, 2021
- Raised at IPO
- $111M
- Valuation at IPO
- $579M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 34
- Patents granted
- 1
- Trademarks
- 3
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $79K
Company Info
- Founded
- 2016
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 122
- HQ
- Harwell, Oxfordshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Apr 29, 2021
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -1.2
- Trend (90d)
- -0.1
- Last leadership hire
- May 1, 2026
- Last layoff mention
- Jan 31, 2025
Acquisitions by Barinthus Biotherapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Barinthus Biotherapeutics
Chief Executive Officer
Co-Founder & Professor of Vaccinology
Chief Financial Officer
Chief Operating Officer
consultant
Chief Business Officer
68
professional contacts at Barinthus Biotherapeutics
Contact execs at Barinthus Biotherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Barinthus Biotherapeutics
Loading news…
FAQs about Barinthus Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.